Hedge Fund - Redmile Group

Jeremy Green Bio, Returns, AUM, Net Worth

Redmile Group is a San Francisco-based asset management group specializing in healthcare investments. The firm offers portfolio management and advisory services across hedge fund and private equity investments.

Jeremy Green is the founder and portfolio manager of Redmile Group. Before establishing Redmile, Jeremy co-founded Steeple Capital served as its research director, and worked as an analyst at Andor Capital. Before relocating to the US in 2004, he was managing director at Citigroup, leading the European Healthcare Research Team covering medical technology, biotech, and healthcare services. Jeremy's previous roles include serving as a Trustee and non-executive director of the Prince of Wales Foundation, and he currently serves as chairman of Prince’s Trust America. He has also served on the board of directors of Alder Biopharmaceuticals (ALDR). Jeremy holds a master’s degree in biological sciences from Oxford University.

Redmile Group is a hedge fund managing discretionary assets totaling $6,473,965,022, according to their Form ADV dated March 2024. With 27 clients, the firm's most recent 13F filing for Q1 2024 reported managing $2,724,553,242 in 13F securities, with a top 10 holdings concentration of 41.91%. Redmile Group's largest holding consists of 1,508,250 shares in Krystal Biotech Inc.

Jeremy Green
Fund Profile
Filing Period:
Fund Name: Redmile Group
Manager Jeremy Green
Portfolio Value $2,724,553,242
Change This QTR +0.97%
Filing Period:
Last update:
No. Security Ticker Shares Value Activity % Port History
1. KRYS 1,508,250 $268,362,923 -13% 9.84%
2. FOLD 13,257,286 $156,170,829 -11% 5.73%
3. IMNM 4,889,554 $120,674,193 +27% 4.42%
4. SRRK 6,419,610 $114,012,274 +1% 4.18%
5. FATE 13,169,057 $96,660,878 3.54%
News, Interviews and Investor Letters